Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

PURPOSE: Patients with acute myeloid leukemia (AML) in remission remain at risk for relapse even after allogeneic hematopoietic cell transplantation (alloHCT). AML measurable residual disease (MRD) status before alloHCT has been shown to be prognostic. Whether modulation of the intensity of the allo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Hourigan, Christopher S., Dillon, Laura W., Gui, Gege, Logan, Brent R., Fei, Mingwei, Ghannam, Jack, Li, Yuesheng, Licon, Abel, Alyea, Edwin P., Bashey, Asad, Deeg, H. Joachim, Devine, Steven M., Fernandez, Hugo F., Giralt, Sergio, Hamadani, Mehdi, Howard, Alan, Maziarz, Richard T., Porter, David L., Scott, Bart L., Warlick, Erica D., Pasquini, Marcelo C., Horwitz, Mitchell E.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2020
Sujets:
RAPID COMMUNICATIONS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164487/
https://ncbi.nlm.nih.gov/pubmed/31860405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.03011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires